Ouabain targets the unfolded protein response for selective killing of HepG2 cells during glucose deprivation

Tulay Ozdemir1, Rukiye Nar, Veli Kilinc

  • 1Gazi State Hospital, Samsun, Turkey.

Insights

Ouabain disrupts the unfolded protein response (UPR) in glucose-deprived cancer cells, selectively inducing cell death. This suggests UPR disruption is a promising strategy for developing novel cancer therapies.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cancer Research

Background:

  • Ouabain is a cardiotonic steroid that inhibits the Na(+)/K(+)-ATPase.
  • The precise relationship between ouabain and the unfolded protein response (UPR) remains unclear.
  • Investigating ouabain's effects on cell proliferation, apoptosis, and UPR is crucial.

Purpose of the Study:

  • To investigate the effects of ouabain on HepG2 cell proliferation, apoptosis, and UPR.
  • To determine if ouabain modulates the UPR transcription program.
  • To explore the potential of ouabain in cancer treatment, particularly under glucose-deprived conditions.

Main Methods:

  • HepG2 cells were treated with varying concentrations of ouabain (0.75–750 nM) with or without 2-deoxyglucose (2-DG).
  • Real-time PCR was used to quantify the expression of UPR-related genes (Grp78, Grp94, CHOP) and other relevant genes (MTJ-1, HKII, MDR-1, MRP-1, HO-1, Par-4).
  • Cell number, viability, and proliferation were monitored using the xCELLigence real-time cell analyzer system.

Main Results:

  • Ouabain treatment modulated the UPR transcription program in HepG2 cells.
  • Ouabain induced cell death in glucose-deprived tumor cells.
  • Ouabain exhibited no cytotoxicity at tested concentrations in normal conditions but was effective under 2-DG stress.

Conclusions:

  • Disrupting the UPR during glucose deprivation offers a potential strategy for selective cancer cell killing.
  • Ouabain's ability to modulate UPR provides a chemical basis for developing UPR-targeting drugs against solid tumors.
  • Ouabain warrants further investigation as an adjunct therapy for conventional cancer treatment.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...